Fundraising Fox
/People
Sign in

Dirk Kersten

Investor

Managing Partner at Forbion · Board director at Dyne Therapeutics

Amsterdam, Netherlands

Writes $100K – $5M checks · typically $1.5M

Find your path to Dirk

227 people in our graph can introduce you to Dirk.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Pieter van der Meer to introduce you to Dirk

You →Pieter · together at Gilde Healthcare (2002–2014) →Dirk

Ask Jamie Chen to introduce you to Dirk

You →Jamie · 2 people · together at Gilde Healthcare →Dirk

Ask Sam Okafor to introduce you to Dirk

You →Sam · 9 people · together at Forbion →Dirk

Sign up to find every way you can get introduced to Dirk

  • Your email: the people you already email who know Dirk
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Dirk
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Dirk Kersten is a Managing Partner at Forbion, which he joined in 2018, where he manages the Forbion Growth Opportunities Fund. Trained as a physicist, he previously served as a Partner at Gilde Healthcare Partners, leading its Boston office, and as a Managing Director at INKEF Capital overseeing healthcare investments. His work spans fund management, deal making, portfolio management, and exit strategies.

Invests in

BiotechHealthtech

Board director at Dyne Therapeutics

Intro paths

→

In turn, Dirk can intro founders to Dyne Therapeutics's investors below.

Dyne Therapeutics's investors · 7

Atlas VentureCambridge · $500K – $1M checks · since 2020ForbionNaarden · since 2020Hercules Capital, Inc.San Mateo · $5M – $500M checks · since 2026MPM BioImpactBoston · $1M – $15M checks · since 2020RA CapitalBoston · since 2020Vida VenturesLos Angeles · since 2020Wellington ManagementBoston · $5M – $50M checks

Co-founders at Dyne Therapeutics

RS
Romesh Subramanian, Ph.D.Executive Officer

Experience

  1. ForbionManaging Partnercurrent2025 — present
  2. ForbionGeneral Partner2018 — 2025
  3. INKEF CapitalManaging Director2014 — 2018The Randstad, Netherlands
  4. Gilde HealthcarePartner & President US office2011 — 2014Greater Boston
  5. Gilde HealthcarePartner & Investment manager2002 — 2011The Randstad, Netherlands
  6. Venture Creation ManagementAssociate2000 — 2001The Randstad, Netherlands
  7. Fource ConsultingConsultant1999 — 2000The Randstad, Netherlands

Skills & more

Venture Capital24Private Equity9

From Dirk's professional profile.

Deals · 1

Dyne TherapeuticsBoard seat

via Forbion · filed Aug 2020 · $115.7M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Led

Ascendis PharmaLanthio PharmaNightbalanceProfibrix

Board seats

NorthSea TherapeuticsSynox Therapeutics

Sources: the firm's website · SEC Form D filings · curated public sources.

Colleagues at Forbion

Alexander Hoffmann
General Partner at Forbion
Alice Vickers
Advisor at Forbion
Antoine Boulanger Piette
Principal at Forbion
Audrey Cacaly
Principal at Forbion
Carlo Incerti
Operating Partner at Forbion
Dirk Mertens
General Partner at Forbion
Dmitrij Hristodorov
General Partner at Forbion
Geert-Jan Mulder
Managing Partner at Forbion

Network5

Alice Vickers
Advisor at Forbion
Antoine Boulanger Piette
Principal at Forbion
Audrey Cacaly
Principal at Forbion
Dmitrij Hristodorov
General Partner at Forbion
Geert-Jan Mulder
Managing Partner at Forbion

Investors connected to Dirk in public investor directories — a warm-intro map.

Frequently asked questions

Who is Dirk Kersten?
Dirk Kersten is a Managing Partner at Forbion, which he joined in 2018, where he manages the Forbion Growth Opportunities Fund. Trained as a physicist, he previously served as a Partner at Gilde Healthcare Partners, leading its Boston office, and as a Managing Director at INKEF Capital overseeing healthcare investments. His work spans fund management, deal making, portfolio management, and exit strategies.
Where does Dirk Kersten work?
Dirk Kersten is Managing Partner at Forbion and Board director at Dyne Therapeutics.
What does Dirk Kersten invest in?
Dirk Kersten invests in Biotech, Healthtech.
What check size does Dirk Kersten write?
Dirk Kersten typically writes checks of $100K – $5M.
What boards does Dirk Kersten sit on?
Dirk Kersten holds tracked board seats at Dyne Therapeutics, Dyne Therapeutics, NorthSea Therapeutics, Synox Therapeutics.
What companies has Dirk Kersten invested in?
Investments tracked here include Ascendis Pharma, Dyne Therapeutics, Lanthio Pharma, Nightbalance, Profibrix, Nightbalance, Northsea Therapeutics, Profibrix, SynOx Therapeutics Ltd, ViCentra, ロゴマーク：AIRNA.
Where did Dirk Kersten go to school?
Dirk Kersten studied at University of Groningen (MSc, Physics).
Does Dirk Kersten lead rounds?
Yes — Dirk Kersten has led 5 tracked investments.

Same school

Shared employers